KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia

KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") proudly congratulates its majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp., for receiving the PATUJÚ Award from Bolivia’s Ministry of Justice and Institutional Transparency in collaboration with the Chamber of Industry, Commerce, and Services of Cochabamba (ICAM).

This prestigious recognition was presented to SIGMA under the category of Implementation of Regulatory Compliance Components, highlighting its organizational commitment to transparency, anti-corruption standards, and corporate ethics. The PATUJÚ Award is granted to institutions that exemplify Bolivia’s highest standards of integrity through compliance programs that protect both internal operations and public trust.

“This recognition reflects the values that define SIGMA’s leadership—integrity, accountability, and service,” said Cesar Herrera, CEO of KRTL Holding Group Inc. “It’s a rare and distinguished honor that validates our belief in partnering with organizations that lead by example.”

As part of Bolivia’s “Hecho en Bolivia” (Made in Bolivia) initiative, the award promotes ethical leadership across industries by spotlighting companies that incorporate best practices in governance, transparency, and corruption prevention. SIGMA’s internal compliance framework—developed under the leadership of Patricia Wilstermann—demonstrates how pharmaceutical companies can build operational excellence around both business performance and social responsibility.

“SIGMA has always worked with integrity and purpose, and this recognition belongs to our entire team,” said Patricia Wilstermann, CEO of SIGMA Corp. “We remain committed to building a corporate culture that delivers transparency, trust, and long-term impact.”

This distinction underscores SIGMA’s role not only as a trusted pharmaceutical partner but also as a model of ethical business practice in Bolivia and beyond. For KRTL, this award reinforces the strength of its international strategy, which prioritizes values-driven partnerships in every market.

The award was formally announced by ICAM and can be viewed via its official LinkedIn post:https://www.linkedin.com/posts/icamcbba_hechoenbolivia-activity-7387648988000460800-3MgA

About KRTL Holding Group, Inc.

KRTL Holding Group, Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.

About KRTL Biotech, Inc.

KRTL Biotech, Inc., a 51% majority-owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), recently completed a merger with Industria Químico-Farmacéutica SIGMA Corp. S.R.L., integrating SIGMA’s decades of pharmaceutical expertise and infrastructure into KRTL’s international life sciences platform. This merger combines KRTL’s research, compliance, and global market access with SIGMA’s advanced Bolivian manufacturing capabilities, aligning both companies to deliver world-class pharmaceutical and nutraceutical solutions.

About Industria Químico Farmacéutica SIGMA Corp SRL

SIGMA is a Bolivian pharmaceutical manufacturer with more than five decades of experience in formulation, quality manufacturing, and commercialization of essential and complementary health products, including pharmaceuticals and nutraceuticals.

For more information:

www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com | www.sigmacorp.com.bo/en/about

Forward-Looking Statements

This press release contains statements and information that, to the extent that they are not historical fact, may constitute  “forward-looking statements” within the meaning of applicable securities legislation. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as “anticipates,” “will,” “believes,” “plans,” “expects,” “intends,” “projects,” “estimates,” “future,” and “opportunity” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments and acquisitions; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law.